The DOI matches its Crossref record; 256 of the 256 references it cites were found in a registry or an index.
The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer
Open accessAbstract
Chemoresistance is a leading cause of morbidity and mortality in cancer and it continues to be a challenge in cancer treatment. Chemoresistance is influenced by genetic and epigenetic alterations which affect drug uptake, metabolism and export of drugs at the cellular levels. While most research has focused on tumor cell autonomous mechanisms of chemoresistance, the tumor microenvironment has emerged as a key player in the development of chemoresistance and in malignant progression, thereby influencing the development of novel therapies in clinical oncology. It is not surprising that the study of the tumor microenvironment is now considered to be as important as the study of tumor cells. Recent advances in technological and analytical methods, especially ‘omics’ technologies, has made it possible to identify specific targets in tumor cells and within the tumor microenvironment to eradicate cancer. Tumors need constant support from previously ‘unsupportive’ microenvironments. Novel therapeutic strategies that inhibit such microenvironmental support to tumor cells would reduce chemoresistance and tumor relapse. Such strategies can target stromal cells, proteins released by stromal cells and non-cellular components such as the extracellular matrix (ECM) within the tumor microenvironment. Novel in vitro tumor biology models that recapitulate the in vivo tumor microenvironment such as multicellular tumor spheroids, biomimetic scaffolds and tumor organoids are being developed and are increasing our understanding of cancer cell-microenvironment interactions. This review offers an analysis of recent developments on the role of the tumor microenvironment in the development of chemoresistance and the strategies to overcome microenvironment-mediated chemoresistance. We propose a systematic analysis of the relationship between tumor cells and their respective tumor microenvironments and our data show that, to survive, cancer cells interact closely with tumor microenvironment components such as mesenchymal stem cells and the extracellular matrix.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–256 of 256
Asimakopoulos, F. A., Hope, C. L., Johnson, M. G., Pagenkopf, A. C., Gromek, K., & Nagel, B. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr1116-468r · Cited by 42
Larionova, I., Zavyalova, M. V., Телегина, Н. С., Buldakov, M. A., Riabov, V., Чердынцева, Н. В., & Kzhyshkowska, J. G. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.08.001 · Cited by 41
Vaupel, P. W., & Mayer, A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-38810-6_11 · Cited by 40
Fletcher, N. M., Belotte, J., Saed, M. G., Memaj, I., Diamond, M. P., Morris, R. T., & Saed, G. M. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.028 · Cited by 39
Shear targeted drug delivery to stenotic blood vessels
Epshtein, M., & Korin, N. (2016) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2016.11.015 · Cited by 38
Mechanism of Inhibition of Sequestration of Protein Kinase C α/βII by Ceramide
Kitatani, K., Idkowiak‐Baldys, J., & Hannun, Y. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609162200 · Cited by 37
Dzobo, K., Vogelsang, M., Thomford, N. E., Dandara, C., Kallmeyer, K., Pepper, M. S., & Parker, M. I. (2016) · Stem Cells International · doi:10.1155/2016/4842134 · Cited by 37
Self-citationRole of periostin in esophageal, gastric and colon cancer
Moniuszko, T., Wincewicz, A., Koda, M., Domysławska, I., & Sulkowski, S. (2016) · Oncology Letters · doi:10.3892/ol.2016.4692 · Cited by 37
Logun, M. T., Bisel, N. S., Tanasse, E. A., Zhao, W., Gunasekera, B., Mao, L., & Karumbaiah, L. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb01083k · Cited by 37
Janczar, S., Janczar, K., Pastorczak, A. K., Harb, H., Paige, A. J. W., Zalewska‐Szewczyk, B., Danilewicz, M., & Mlynarski, W. M. (2017) · Cancers · doi:10.3390/cancers9010002 · Cited by 36
Epigenetic and genetic heterogeneity in metastasis
Alderton, G. K. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.11 · Cited by 36
Zhao, H., & Väänänen, H. K. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.051204 · Cited by 35
Chemoresistance in Cancer Stem Cells and Strategies to Overcome Resistance
(2014) · Chemotherapy Open access · doi:10.4172/2167-7700.1000125 · Cited by 34
Brown, F. C., Cifani, P., Drill, E. N., He, J., Still, E., Zhong, S., Balasubramanian, S., Pavlick, D., Yilmazel, B., Knapp, K. M., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14413 · Cited by 34
Lee, K. Y. J., Lee, G. Y., Lane, L. A., Li, B., Wang, J., Lu, Q., Wang, Y., & Nie, S. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00224 · Cited by 34
Persistence to anti-cancer treatments in the stationary to proliferating transition
Mizrahi, S. P., Gefen, O., Simon, I., & Balaban, N. Q. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1248006 · Cited by 34
The plasticity of germ cell cancers and its dependence on the cellular microenvironment
Nettersheim, D., & Schorle, H. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13082 · Cited by 34
Chan, R., Sethi, P., Jyoti, A., McGarry, R. C., & Upreti, M. (2016) · Radiation Research · doi:10.1667/rr14285.1 · Cited by 33
Suzuki, S., Itakura, S., Matsui, R., Nakayama, K., Nishi, T., Nishimoto, A., Hama, S., & Kogure, K. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.6b01688 · Cited by 33
[10]-Gingerol Reverts Malignant Phenotype of Breast Cancer Cells in 3D Culture
Fuzer, A. M., Lee, S., Mott, J. D., & Cominetti, M. R. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25906 · Cited by 33
A stiff extracellular matrix is associated with malignancy in peripheral neuroblastic tumors
Tadeo, I., Berbegall, A. P., Navarro, S., Castel, V., & Noguera, R. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26449 · Cited by 32
Potential immunotherapy targets in recurrent cervical cancer
Ring, K. L., Yemelyanova, A. V., Soliman, P. T., Frumovitz, M. M., & Jazaeri, A. A. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.02.027 · Cited by 31
Cheema, P. K., Raphael, S. J., El-Maraghi, R. H., Li, J., McClure, R. F., Zibdawi, L., Chan, A., Victor, J. C., Dolley, A., & Dziarmaga, A. (2017) · Current Oncology · doi:10.3747/co.24.3266 · Cited by 31
Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis
Bilen, M. A., Hess, K. R., Campbell, M. T., Wang, J., Broaddus, R. R., Karam, J. A., Ward, J. F., Wood, C. G., Choi, S. L., Rao, P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13380 · Cited by 28
Stem Cell Plasticity and Niche Dynamics in Cancer Progression
Picco, N., Gatenby, R. A., & Anderson, A. R. A. (2016) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2016.2607183 · Cited by 28
Hypoxia attenuates the proinflammatory response in colon cancer cells by regulating IκB
Müller-Edenborn, K., Léger, K., Garzon, J. F. G., Oertli, C., Mirsaidi, A., Richards, P. J., Rehrauer, H., Spielmann, P., Hoogewijs, D., Borsig, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3961 · Cited by 27
Periostin contributes to arsenic trioxide resistance in hepatocellular carcinoma cells under hypoxia
Liu, Y., Gao, F., & Song, W. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.052 · Cited by 26
Mahalakshmi, R., Pallikonda, H. A., & Mahadevan, V. (2017) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2017.1302820 · Cited by 25
Fukazawa, S., Shinto, E., Tsuda, H., Ueno, H., Shikina, A., Kajiwara, Y., Yamamoto, J., & Hase, K. (2015) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyv037 · Cited by 24
Platinum based radiochemotherapies: Free radical mechanisms and radiotherapy sensitizers
Fong, C. W. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.07.006 · Cited by 24
McLane, J. S., & Ligon, L. A. (2016) · Cancer Microenvironment · doi:10.1007/s12307-016-0188-z · Cited by 24
Biomaterials to suppress cancer stem cells and disrupt their tumoral niche
García-Mazás, C., Csaba, N., & García-Fuentes, M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.013 · Cited by 24
Hu, Z., Dong, N., Lu, D., Jiang, X., Xu, J., Wu, Z., Zheng, D., & Wechsler, D. S. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.01.007 · Cited by 23
Pucciarelli, D., Lengger, N., Takáčová, M., Csáderová, L., Bartošová, M., Breiteneder, H., Pastoreková, S., & Häfner, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4888 · Cited by 22
Song, J., Dong, D., Huang, Y., Zang, Y., Liu, Z., & Tian, J. (2016) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2016.7590937 · Cited by 22
Gehler, S., Compere, F. V., & Miller, A. M. (2017) · International Journal of Breast Cancer · doi:10.1155/2017/9619734 · Cited by 22
Cancer Cytokines and the Relevance of 3D Cultures for Studying Those Implicated in Human Cancers
Ravi, M., Subramaniyan, A., & Balasubramanian, H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25970 · Cited by 21
Regulation of the hypoxic tumor environment in hepatocellular carcinoma using RNA interference
Choi, S. H., & Park, J. Y. (2017) · Cancer Cell International · doi:10.1186/s12935-016-0374-6 · Cited by 20
Mesenchymal stromal cells promote osteosarcoma stemness and migratory potential via IL-6 secretion
Cortini, M., Avnet, S., Bonuccelli, G., & Baldini, N. (2016) · Bone Abstracts · doi:10.1530/boneabs.5.cabs.op2.2 · Cited by 18
Sundaram, D. N. M., Kucharski, C., Parmar, M. B., Bahadur, K., & Uludağ, H. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201600430 · Cited by 18
Tourell, M. C., Shokoohmand, A., Landgraf, M., Holzapfel, N. P., Poh, P. S. P., Loessner, D., & Momot, K. I. (2017) · Scientific Reports · doi:10.1038/srep42905 · Cited by 18
Modeling dynamics of mutants in heterogeneous stem cell niche
Shahriyari, L., & Mahdipour–Shirayeh, A. (2017) · Physical Biology · doi:10.1088/1478-3975/aa5a61 · Cited by 16
A new case of “de novo” BRCA 1 mutation in a patient with early‐onset breast cancer
Antonucci, I., Provenzano, M., Sorino, L., Rodrigues, M., Palka, G., & Stuppia, L. (2017) · Clinical Case Reports · doi:10.1002/ccr3.718 · Cited by 16
Burmakin, M., van Wieringen, T., Olsson, P. O., Stuhr, L. E. B., Åhgren, A., Heldin, C., Reed, R. K., Rubin, K., & Hellberg, C. B. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1142-7 · Cited by 15
Spicer, G. L. C., Azarin, S. M., Yi, J., Young, S. T., Ellis, R. J., Bauer, G. M., Shea, L. D., & Backman, V. (2016) · Physics in Medicine and Biology · doi:10.1088/0031-9155/61/19/6892 · Cited by 14
Takada, M., Nagai, S. E., Haruta, M., Sugino, R. P., Tozuka, K., Takei, H., Ohkubo, F., Inoue, K., Kurosumi, M., Miyazaki, M., et al. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22445 · Cited by 14
Wang, G. Y., Wood, C. N., Dolorito, J., Libove, E., & Epstein, E. H. (2017) · Oncogene · doi:10.1038/onc.2017.12 · Cited by 11
Villegas‐Pineda, J. C., Toledo‐Leyva, A., Osorio‐Trujillo, J. C., Hernández‐Ramírez, V. I., & Talamás‐Rohana, P. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.01.010 · Cited by 10
da Silva, E. F. G., Krause, G. C., Lima, K. G., Haute, G. V., Pedrazza, L., de Mesquita, F. C., Basso, B. D. S., Catarina, A. V., Nunes, F. B., & de Oliveira, J. R. (2016) · Oncology Reports · doi:10.3892/or.2016.5111 · Cited by 9
Hu, X., Baytak, E., Li, J., Akman, B., Okay, K., Hu, G., Scuto, A., Zhang, W., & Küçük, C. (2017) · Leukemia Research · doi:10.1016/j.leukres.2017.01.001 · Cited by 8
Jin, J., Pastrello, D., Penning, N. A., & Jones, A. T. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.03.004 · Cited by 7
Intratumoral heterogeneity and intraclonal plasticity: from warburg to oxygen and back again
Conrad, C. A., Fueyo-Margareto, J., & Gomez‐Manzano, C. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou121 · Cited by 6
Stem Cell Plasticity and Niche Dynamics in Cancer ProgressionPreprint
Picco, N., Gatenby, R. A., & Anderson, A. R. A. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/056762 · Cited by 5
Williams, M., & Catchpoole, D. R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140713042 · Cited by 3
Tan, R. Y. P., Walsh, M., Howard, A., & Winship, I. (2017) · Australasian Journal of Dermatology · doi:10.1111/ajd.12605 · Cited by 3
Cowan (2001) · doi:10.1002/1097-0215(20010101)91:1<120::aid-ijc1021>3.0.co;2-y
Cited by
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018) · Stem Cells International · doi:10.1155/2018/5416923 · Cited by 994
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Hoarau-Véchot, J., Rafii, A., Touboul, C., & Pasquier, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010181 · Cited by 489
Qin, X., Guo, H., Wang, X., Zhu, X., Yan, M., Wang, X., Xu, Q., Shi, J., Lu, E., Chen, W., et al. (2019) · Genome Biology · doi:10.1186/s13059-018-1604-0 · Cited by 431
Metadata
- Authors
- Senthebane, D. A., Rowe, A., Thomford, N. E., Shipanga, H., Munro, D., Mazeedi, M. A. M. A., Almazyadi, H. A. M., Kallmeyer, K., Dandara, C., Pepper, M. S., Parker, M. I., & Dzobo, K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-07-21
- Volume
- 18
- Issue
- 7
- Pages
- 1586
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2738462696
- Cited by
- 399
- References
- 256
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.